Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | European Journal of Medical Research

Fig. 2

From: Long non-coding RNA H19 promotes cervical cancer development via targeting the microRNA-140/ALDH1A1 axis

Fig. 2

The malignant biological properties of cervical cancer cells were inhibited upon suppression of lncRNA H19. Hela cells were transfected with either sh-H19 or sh-NC (negative control). A qRT-PCR analysis demonstrated the expression levels of lncRNA H19 in cells. B Cell viability of Hela cells was assessed using a CCK-8 assay (OD450 nm). C Colony formation assay was conducted to assess the proliferative capacities of Hela cells. D Flow cytometry analysis was performed to detect the level of apoptosis in Hela cells. E Scratch wound healing assay was conducted to evaluate the migratory abilities of Hela cells (scale bar: 50 μm). F Transwell assay was performed to determine the invasive abilities of Hela cells (scale bar: 50 μm). G Western blotting was employed to explore the expression levels of apoptosis related proteins Bcl-2 and Bax in Hela cells. ** P < 0.01 compared to the sh-NC group

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us